These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2983462)

  • 1. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model.
    Hamilton JD; Seaworth BJ
    Transplantation; 1985 Mar; 39(3):290-6. PubMed ID: 2983462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The source of murine cytomegalovirus in mice receiving kidney allografts.
    Klotman ME; Starnes D; Hamilton JD
    J Infect Dis; 1985 Dec; 152(6):1192-6. PubMed ID: 2999256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for reactivation of CMV from latency.
    Hummel M; Abecassis MM
    J Clin Virol; 2002 Aug; 25 Suppl 2():S123-36. PubMed ID: 12361763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
    Rabinovitch T; Oh JO; Minasi P
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of cytomegalovirus infection in mice by skin graft.
    Shelby J; Saffle JR; Kern ER
    J Trauma; 1988 Feb; 28(2):203-6. PubMed ID: 2831371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.
    Jordan MC; Takagi JL; Stevens JG
    J Infect Dis; 1982 May; 145(5):699-705. PubMed ID: 6281340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of CMV transmission following kidney transplantation.
    Li Z; Wang X; Yan S; Zhang Z; Jie C; Sustento-Reodica N; Hummel M; Abecassis M
    Am J Transplant; 2012 Apr; 12(4):1024-8. PubMed ID: 22226173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of latent murine cytomegalovirus from kidney.
    Porter KR; Starnes DM; Hamilton JD
    Kidney Int; 1985 Dec; 28(6):922-5. PubMed ID: 3003444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.
    Zhang Z; Qiu L; Yan S; Wang JJ; Thomas PM; Kandpal M; Zhao L; Iovane A; Liu XF; Thorp EB; Chen Q; Hummel M; Kanwar YS; Abecassis MM
    Am J Transplant; 2019 Sep; 19(9):2421-2433. PubMed ID: 30947382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model.
    Cheung KS; Lang DJ
    J Infect Dis; 1977 May; 135(5):841-5. PubMed ID: 192814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.
    Seckert CK; Renzaho A; Reddehase MJ; Grzimek NK
    Med Microbiol Immunol; 2008 Jun; 197(2):251-9. PubMed ID: 18365252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.
    Cook CH; Bickerstaff AA; Wang JJ; Zimmerman PD; Forster MR; Nadasdy T; Colvin RB; Hadley GA; Orosz CG
    Am J Transplant; 2009 Jan; 9(1):42-53. PubMed ID: 18976295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cytomegalovirus infection following cardiac transplantation in a murine model.
    Rubin RH; Wilson EJ; Barrett LV; Medearis DN
    Transplantation; 1984 Mar; 37(3):306-10. PubMed ID: 6322391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.
    Wu BC; Dowling JN; Armstrong JA; Ho M
    Science; 1975 Oct; 190(4209):56-8. PubMed ID: 170676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of latent CMV in the rat.
    Bruggeman CA
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):22-4, discussion 24. PubMed ID: 1648829
    [No Abstract]   [Full Text] [Related]  

  • 19. Aging and reactivation of latent murine cytomegalovirus.
    Schmader KE; Rahija R; Porter KR; Daley G; Hamilton JD
    J Infect Dis; 1992 Dec; 166(6):1403-7. PubMed ID: 1331252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.
    Bale JF; O'Neil ME
    J Virol; 1989 Jun; 63(6):2667-73. PubMed ID: 2542580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.